1. Academic Validation
  2. The APOBEC3C crystal structure and the interface for HIV-1 Vif binding

The APOBEC3C crystal structure and the interface for HIV-1 Vif binding

  • Nat Struct Mol Biol. 2012 Oct;19(10):1005-10. doi: 10.1038/nsmb.2378.
Shingo Kitamura 1 Hirotaka Ode Masaaki Nakashima Mayumi Imahashi Yuriko Naganawa Teppei Kurosawa Yoshiyuki Yokomaku Takashi Yamane Nobuhisa Watanabe Atsuo Suzuki Wataru Sugiura Yasumasa Iwatani
Affiliations

Affiliation

  • 1 Clinical Research Center, Department of Infectious Diseases and Immunology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Abstract

The human apolipoprotein B mRNA-editing Enzyme catalytic polypeptide-like 3 (APOBEC3, referred to as A3) proteins are cellular cytidine deaminases that potently restrict retrovirus replication. However, HIV-1 viral infectivity factor (Vif) counteracts the Antiviral activity of most A3 proteins by targeting them for proteasomal degradation. To date, the structure of an A3 protein containing a Vif-binding interface has not been solved. Here, we report a high-resolution crystal structure of APOBEC3C and identify the HIV-1 Vif-interaction interface. Extensive structure-guided mutagenesis revealed the role of a shallow cavity composed of hydrophobic or negatively charged residues between the α2 and α3 helices. This region is distant from the DPD motif (residues 128-130) of APOBEC3G that participates in HIV-1 Vif interaction. These findings provide insight into Vif-A3 interactions and could lead to the development of new pharmacologic anti-HIV-1 compounds.

Figures